,0
symbol,ZOM
price,0.0947
beta,-0.34477
volAvg,23403523
mktCap,53415632
lastDiv,0.0
range,0.063-0.499
changes,0.0147
companyName,Zomedica Pharmaceuticals Corp
currency,USD
cik,0001684144
isin,CA98979F1071
cusip,98979F107
exchange,NYSE American
exchangeShortName,AMEX
industry,Drug Manufacturers General Specialty & Generic
website,http://www.zomedica.com/
description,"Zomedica Pharmaceuticals Corp. operates as a development stage veterinary diagnostic and pharmaceutical company. The company is headquartered in Ann Arbor, Michigan and currently employs 27 full-time employees. The firm is engaged in developing products for companion animals, such as canine, feline, and equine by focusing on needs of clinical veterinarians. The company is focused on developing three diagnostic platforms, a Bulk Acoustic Wave sensor-based veterinary point-of-care diagnostic platform for performing immunodiagnostic testing, a Raman spectroscopy-based point-of-care diagnostic platform for the detection of pathogens, and liquid biopsy assays for the detection of cancer, along with related consumables. The Companyâ€™s TRUFORMA product candidate is an investigational device being developed as a point-of-care biosensor platform. ZM-020 is its diagnostic platform being developed to screen for a range of pathogens in companion animal feces, urine, respiratory, and dermatological samples. The company is developing ZM-017 as a canine cancer liquid biopsy platform."
ceo,Mr. Shameze Rampertab
sector,Healthcare
country,US
fullTimeEmployees,28
phone,17343692555
address,"100 Phoenix Drive, Suite 180"
city,Ann Arbor
state,MICHIGAN
zip,48108
dcfDiff,-1.22
dcf,0.0
image,https://financialmodelingprep.com/image-stock/ZOM.png
ipoDate,2013-10-28
defaultImage,False
